Targeting Latency Switch in EBV+ Lymphomas Grant

Overview

date/time interval

July 1, 2022 -

awarded by

National Cancer Institute

administered by

Pediatrics

sponsor award ID

1 R37 CA262517-01A1

Affiliation

contributor

Elemento, Olivier Co-Investigator 2022 - 2027
Inghirami, Giorgio Ga. Co-Investigator 2022 - 2027
Kong, Isabella Key Personnel 2022 - 2027